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Background. The predominant mode of transmission of human immunodeficiency virus (HIV) in 
Europe is male-to-male transmission. Men who have sex with men (MSM) are deferred from donating 
blood in many countries, but nevertheless do donate blood. Based on data from 34 countries, we 
estimated the proportion of MSM screened for HIV in the context of a blood donation and identified 
individual factors associated with this HIV screening in order to propose possible public health 
interventions. 
Materials and methods. In 2010, the first European MSM Internet Survey (EMIS) collected self-
reported data on HIV testing from >180,000 MSM in 38 European countries. Using logistic regression, 
demographic and behavioural factors associated with screening for HIV in blood establishments were 
identified. Stratified by European sub-region, we analysed the proportion of MSM screening in blood 
establishments by time elapsed since last negative HIV test. 
Results. Donor eligibility criteria for MSM vary across Europe with most countries using 
permanent deferral. The Western region had the lowest (2%) proportion of MSM screened in blood 
establishments and the Northeastern region had the highest (14%). Being <25 years old, not disclosing 
sexual attraction to men, never having had anal intercourse with a man, having a female partner, living 
in a rural area, and certain European sub-regions or countries of residence increased the likelihood 
of being screened in blood establishments. 
Discussion. In spite of deferral policies, MSM are screened for HIV in the context of blood 
donations. Gay-friendly testing services are rare in rural areas, and young men might be reluctant 
to disclose their sexual orientation. Recent developments, such as home sampling, might offer new 
testing possibilities for those not reached by established services yet wishing to know their HIV status. 
Donor selection procedures should be improved. Both interventions might help to further reduce the 
risk of transfusion-transmitted infections. 
Keywords: men who have sex with men, blood donation, HIV, screening, behavioural surveillance.
Introduction
In the early 1980s, national authorities established 
measures to prevent human immunodeficiency virus 
(HIV) from entering the blood supply. Permanent 
deferral of men who have sex with men (MSM) from 
donating blood was an attempt to increase blood safety 
in response to the AIDS epidemic in the 1980s. In 1985, 
tests to detect the virus became available. Nevertheless, 
a residual risk of transfusion-transmitted HIV remains. 
This is mainly due to undetected infectious donations 
in the window period of an infection when infectious 
disease markers are not yet detectable. In 1985, the first 
generation HIV antibody tests had a window period of 
approximately 56 days1. To reduce the residual risk of 
transfusion-transmitted HIV infections, HIV nucleic 
acid amplification testing to screen blood donations 
was implemented in most European countries starting in 
19971,2. This reduced the window period for potentially 
infectious donations from approximately 56 to less 
than 14 days3. Many countries worldwide retain the 
permanent deferral of potential donors with a sexual 
behaviour that puts them "at high risk" of acquiring 
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infectious diseases which are transmissible by blood, 
including HIV4. 
In addition to donor screening, donor history 
questionnaires and donor interviews are used to identify 
eligible donors according to defined donor deferral 
criteria. These criteria aim to minimise the risks for 
donors as well as for recipients and include for instance 
medical conditions, travelling, invasive procedures such 
as tattooing, and sexual exposures.
With respect to sexual exposures, European Union 
(EU) legislation5 distinguishes behaviour "at risk" 
and "at high risk" linked to temporary and permanent 
deferral from blood donation, respectively. No further 
definition of "risk" and "high risk" is given, nor are 
risk categories defined. Member States are required to 
transfer European regulations into national law. In order 
to comply with the EU directive, most member states 
kept the permanent deferral for MSM that was already 
in place since the identification of the HIV, mainly 
because of the epidemiological situation. In 2012, the 
predominant mode of HIV transmission in European 
countries was male-to-male sexual transmission, 
accounting for 40% of all new HIV diagnoses6. While 
MSM constitute approximately 3% of the adult male 
population7,8, they represented more than 30% of all 
people newly diagnosed with HIV in ten countries and 
more than half of all newly diagnosed people in another 
nine countries6. The rate of HIV diagnoses per 100,000 
population decreased slightly from 6.4 per 100,000 in 
2006 to 6.2 per 100,000 in 2012 and yet the burden of 
new diagnoses attributed to sex between men increased 
by 11% since 20066. 
The permanent deferral of MSM from donating blood 
is discussed intensively9. Irrespective of deferral criteria, 
some MSM donate blood. The first pan-European MSM 
Internet Survey (EMIS) in 2010 included questions on 
HIV testing sites within the context of HIV screening or 
diagnosis. We estimated the proportions of MSM who 
reported that they were last screened for HIV in the 
context of a blood donation for 34 European countries 
in the EMIS dataset and identified associated individual 
factors. Based on these findings we propose and discuss 
possible public health interventions to reduce the use of 
blood establishments for HIV test-seeking by groups 
with increased risk of HIV infection. 
Materials and methods 
Review of current practices
We searched literature in PubMed and Scopus as 
well as the grey literature to generate an overview of 
the implementation of the European Council directive 
2004/33/EC with respect to MSM and blood donation 
in 2010 and expanded the search to other countries with 
participants in EMIS.
Population and data collection
The EMIS survey sample and methods have been 
fully described in detail elsewhere10,11. In short, five 
primary and 77 secondary partners active in public health 
or in the MSM community developed a questionnaire in 
25 different languages which was featured in gay online 
social media and by gay community organisations. 
Users of gay online media were invited by instant 
messages or banner advertisements to participate in an 
anonymous online survey. The core slogan to promote 
the survey was "Be part of something huge". It was 
intended to promote the benefits to the community 
of taking part in the study and to be intriguing and 
mildly suggestive of the sexual content of the survey. 
The questionnaire explored sexual health, access to 
healthcare, behaviours as well as socio-economic 
factors. The typical completion time was 20 minutes. No 
financial incentives were given. No IP addresses were 
collected. The survey was accessible online from June 
6 to August 31, 2010. More background information, 
including the English version of the questionnaire, is 
available at www.emis-project.eu.
Questionnaire items used for this study
The questions on blood donation depended on the 
respondent's answer regarding his HIV status. Men 
who indicated that they were HIV-positive were asked 
for the year of the diagnosis. Men who replied that 
they had screened negative were asked when they had 
had their last test. All respondents were asked about 
the setting and could choose from ten options: primary 
care, private practice, hospital outpatient clinic, hospital 
as an inpatient, HIV testing service, blood donation, 
home testing, bar/pub/club/sauna, mobile medical unit, 
or elsewhere. 
Data analysis
We explored the regulations regarding MSM and 
blood donation in effect in the various countries in 
2010, classifying them as permanent deferral, deferral 
for six or 12 months, deferral based on individual risk 
assessment, no MSM-specific rule, and information 
unavailable (if no or contradictory information was 
found). We calculated the proportions of participants 
using blood establishments among all testing sites 
regardless of HIV status. 
We classified replies on time of last HIV screening 
into three categories -more than five years previously, 
between one and five years previously, and within 
the preceding year- and stratified countries by 
nine geographic regions, as proposed by the EMIS 
investigators11. We classified testing venues into two 
groups: blood establishment versus all others. The 
dataset had already been checked for consistency. 
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Participants had provided informed consent and were at 
or above the age of homosexual consent in their country 
of residence. Respondents who did not express sexual 
preference for other men or who did not report sexual 
contacts with other men had already been excluded11. 
However, we further excluded people who gave 
inconsistent answers on their age or their HIV testing 
history. In addition, participants who had never been 
tested for HIV, had not received their results or did not 
indicate where they had been tested were excluded. 
Those tested while hospitalised were excluded because 
most HIV tests would not have been self-initiated in this 
setting. Finally, we excluded countries with less than 
100 valid questionnaires.
We considered HIV testing at a blood establishment 
as opposed to other testing sites as an outcome and 
performed a logistic regression analysing contributing 
factors including age, population size of place of 
residence, seeking testing for sexually transmitted 
infections (STI) within the preceding 12 months and 
presence of symptoms when doing so, anal intercourse 
with men, relationships with women, social disclosure 
of having sex with men (outness) and EMIS geographic 
region. We performed this analysis for HIV-negative 
and HIV-positive participants separately because, on the 
one hand, social, demographic and behavioural factors 
might have been influenced following the HIV diagnosis 
and, on the other, because participants who screened 
negative within the context of a blood donation might 
return in the future. 
To describe regional developments in screening at 
blood establishments, we calculated the time elapsed 
(within the preceding year, within one-five years 
previously, more than five years previously) since 
the last negative HIV test in the context of a blood 
donation for MSM divided by geographic region to 
explore whether the proportion of MSM testing at blood 
establishments remained stable over time.
We used Stata® 13.1 (StataCorp, College Station, TX, 
USA) to calculate odds ratio (OR), p-values, standard 
errors and 95% confidence intervals (95% CI). 
Human subject protection
The Research Ethics Committee of the University of 
Portsmouth, United Kingdom (REC application number 
08/09:21) approved EMIS 2010.
Results
Human immunodeficiency testing and blood 
donation among men who have sex with men
The dataset, cleaned according to the EMIS study 
protocol10 and provided for analysis to study partners, 
contained 174,209 valid questionnaires. The EMIS 
population has been described fully elsewhere10,11. We 
excluded questionnaires containing discrepant answers 
on the participant's age or his HIV testing history (n=302, 
0.13%). We further excluded participants who did not 
test for HIV (n=50,629, 29%) or had never received 
their test result (n=1,216, 0.70%), participants who did 
not indicate where they tested for HIV (n=204, 1.1%), 
and participants who tested for HIV as an in-patient 
(n=6,382, 3.7%). Finally, we excluded those from 
countries with fewer than 100 valid questionnaires 
(Bosnia and Herzegovina, Moldova, the former 
Yugoslav Republic of Macedonia and Malta) (n=264, 
0.15%). Our analysis was thus based on 115,212 (66%) 
questionnaires. General practitioners, family doctors, 
and doctors in private practice accounted for 38% of 
test settings, followed by outpatient clinics (27%), 
dedicated HIV testing services (24%), bars, pubs, clubs, 
saunas or mobile medical units (0.7%) and home testing 
(0.7%). Three percent of MSM said they tested without 
specifying the location ("elsewhere"). Blood donation 
represented 6.3% of all HIV test settings, with 2.9% 
among participants diagnosed positive and 6.7% among 
those tested negative (Table I).
Table I - Number of participants using different settings to test or screen for HIV in 34 European countries, EMIS 2010.
HIV positive 
(diagnosis)
HIV negative 
(last screening)
Total
N % N % N %
General practitioner, family doctor, private physician 5,086 43.2 38,908 37.6 43,994 38.2
At a hospital or clinic as an out-patient 3,493 29.7 27,326 26.4 30,819 26.7
At an HIV testing service 2,406 20.4 25,026 24.2 27,432 23.8
At a blood bank, while donating blood 344 2.9 6,950 6.7 7,294 6.3
Used a home testing kit 48 0.4 731 0.7 779 0.7
Mobile medical unit 29 0.3 822 0.8 851 0.7
In a bar or pub, club or sauna 15 0.1 408 0.4 423 0.4
Elsewhere not otherwise specified 359 3.0 3,262 3.2 3,621 3.1
Total 11,780 100 103,432 100 115,212 100
EMIS: European Men-who-have-sex-with-men Internet Survey; HIV: human immunodeficiency virus.
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Implementation of regulations regarding men who 
have sex with men and blood donation
At the time of the survey in 2010, permanent 
deferral of MSM was in place in most member 
states. For the 34 countries represented in EMIS, 
we could confirm rules regarding MSM in 25 
countries: permanent deferral was in place in 20 
countries, deferral for six or 12 months after the last 
sexual contact was used in two EU-member states, 
two member states implemented an individual risk 
assessment and one country had no MSM-specific 
policy in place. 
The proportions of participants reporting HIV tests in 
blood establishments were highest in Lithuania (17%), 
Latvia (14%), Austria (12%) and Croatia (12%) and 
lowest in the Netherlands (1.3%), Norway (1%) and 
the United Kingdom (0.9%). The reported proportions 
were above 10% in nine countries, between 5-9.9% 
in 12 countries, between 2-4.9% in six countries and 
less than 2% in seven countries. When aggregated 
by regulations in place in each country, the groups 
were statistically different. The proportions of 
MSM donating blood were highest in countries with 
individual risk assessment (9.4% [95% CI: 9.0-9.8%]), 
somewhat lower in countries with a limited deferral 
period (7.4% [95% CI: 6.1-8.8%]) and lowest in 
countries with permanent deferral (5.4% [95% CI: 
5.3-5.6%]), yet blood donation took place in spite of 
the permanent deferral rule and varied greatly among 
countries (range, 0.9-12.1%) (Table II). 
Characteristics of men who have sex with men 
who last screened human immunodeficiency 
virus negative or tested positive while donating 
blood 
Compared with those testing elsewhere, MSM 
diagnosed with HIV at blood establishments were 
more likely to be under 25 years old, live in a smaller 
town, be in a steady relationship with a woman and 
less out about their sexual attraction. The EMIS 
sub-region of the individual's country of residence 
increased odds to donate blood in only three regions 
(Table IIIa).
Compared with those testing elsewhere, MSM who 
last screened HIV-negative in blood establishments 
were more likely to be under 25 years old, live in 
a smaller town, be in a steady relationship with 
a woman and less likely to have engaged in anal 
intercourse with a man, to be screened for other STI 
in the absence of symptoms, and to be out about their 
sexual attraction. Compared to the EMIS sub-region 
West, all other sub-regions contributed, in addition 
to the size of the place of residence, to the likelihood 
of seeking out blood donation (Table IIIb).
Time lapse since the last negative human 
immunodeficiency virus screening at a blood 
establishment by EMIS sub-region
Blood establishments, among all testing locations, 
play a role ranging from a cumulative 1.4% in the West 
to 14.2% in the Northeastern sub-region. Stratified by 
time since last HIV test and region, we observed that in 
regions with a low proportion of blood establishments 
as testing sites, the proportion of MSM reporting blood 
establishments as testing sites remained stable, notably 
in the West, Northwest and East. However, in regions 
with a higher proportion of blood establishments as 
testing sites, we observed that MSM with HIV tests 
within the preceding year more often reported blood 
establishments as a testing site than MSM who had 
tested longer ago. Compared to other testing options, 
blood establishments were visited proportionally more 
frequently. The proportion of all HIV screening tests in 
blood establishments in the EMIS sample exceeded 10% 
within the preceding year and represented a substantial 
testing venue for MSM in five sub-regions: Central-
West (10.3%), non-EU Southeast (10.4%), Southwest 
(10.8%), Central-East (11.7%) and Northeast (18.0%) 
(Figure 1).
Discussion
Despite being based on the same EU directive, 
regulations regarding blood donation depending on 
behaviour and risk vary across Europe and range from 
lifelong deferral of MSM to a temporary deferral after 
last sex with a man to individual risk assessment by 
a physician. MSM are the most affected group in 
the HIV epidemic in Europe6,12-16. Nevertheless, the 
permanent deferral of MSM from blood donation in 
most European countries is subject to intense debate and 
legal challenges17-19. In order to achieve a harmonised 
European approach, a working group at the Council of 
Europe was created to provide scientific grounds for 
donor deferrals due to different sexual behaviour20,21. 
A Resolution of the Committee of Ministers concluded 
that countries should only decide on a temporary deferral 
policy for a given risky sexual behaviour when having 
demonstrated that this sexual behaviour does not put 
the donors at high risk of acquiring severe blood-borne 
infectious diseases20. The United Kingdom analysed 
their HIV surveillance data and initiated a change in 
deferral policy in 2011 and now restricts only men who 
have had sex with another man within the preceding 
12 months. The United Kingdom is also the country in 
which MSM were least likely to screen themselves in the 
context of a blood donation, which indicates that most 
testing needs are met elsewhere. Donor surveillance and 
well-designed mathematic modelling of the residual risk 
will indicate whether the safety of the blood supply has 
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Table II - Setting of last HIV test as reported by EMIS participants who had been tested for HIV, 2010 and deferral policies 
for men who have sex with men in 2010.
Regulation in 2010 Country Test in blood 
establishment
Test in other
setting
Number of participants 
reporting testing
% blood 
establishment
% CI
Permanent deferral Austria 338 2,462 2,800 12.1% 10.9-13.3%
Croatia 31 226 257 12.1% 8.6-16.7%
Greece 176 1,541 1,717 10.3% 8.9-11.8%
Turkey 81 765 846 9.6% 7.8-11.8%
Estonia 32 308 340 9.4% 6.7-13.0%
Czech Republic 121 1,166 1287 9.4% 7.9-11.1%
Germany 2,879 32,170 35,049 8.2% 7.9-8.5%
Slovenia 32 455 487 6.6% 4.7-9.2%
Portugal 235 3,374 3,609 6.5% 5.8-7.4%
Switzerland 163 3,647 3,810 4.3% 3.7-5.0%
Finland 42 1,162 1,204 3.5% 2.6-4.7%
Luxemburg 6 207 213 2.8% 1.3-6.2%
Sweden 54 2,160 2,214 2.4% 1.9-3.2%
Belgium 54 3,048 3,102 1.7% 1.3-2.3%
France 154 8,773 8,927 1.7% 1.5-2.0%
Denmark 19 1,204 1,223 1.6% 1.0-2.4%
Ireland 20 1,315 1,335 1.5% 1.0-2.3%
Netherlands 37 2,851 2,888 1.3% 0.9-1.8%
Norway 13 1,307 1,320 1.0% 0.6-1.7%
United Kingdom 107 12,135 12,242 0.9% 0.7-1.1%
Subtotal 4,594 80,276 84,870 5.4% 5.3-5.6%
6- or 12-month 
deferral
Slovakia 33 228 261 12.6% 9.1-17.3%
Hungary 72 1,092 1,164 6.2% 4.9-7.7%
Subtotal 105 1,320 1,425 7.4% 6.1-8.8%
Individual risk 
assessment
Italy 1,145 9,452 10,597 10.8% 10.2-11.4%
Spain 725 8,599 9,324 7.8% 7.2-8.3%
Subtotal 1,870 18,051 19,921 9.4% 9.0-9.8%
No specific rule Russian Federation 177 3,064 3,241 5.5% 4.7-6.3%
Unavailable 
information 
Lithuania 42 197 239 17.6% 13.2-23.0%
Latvia 46 272 318 14.5% 11.0-18.8%
Poland 194 1,446 1,640 11.8% 10.4-13.5%
Serbia 58 496 554 10.5% 8.2-13.3%
Romania 110 1,000 1,110 9.9% 8.3-11.8%
Bulgaria 42 581 623 6.7% 5.0-9.0%
Cyprus 9 137 146 6.2% 3.2-11.5%
Ukraine 40 881 921 4.3% 3.2-5.9%
Belarus 7 197 204 3.4% 1.6-7.1%
Subtotal 548 5,207 5,755 9.5% 8.8-10.3%
Total  7,294 107,918 115,212 6.3% 6.2-6.5%
HIV: human immunodeficiency virus; EMIS: European Men-who-have-sex-with-men Internet Survey; 95% CI: 95% confidence interval for the EMIS dataset.
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Table IIIa  - Factors associated with having been tested for HIV in the context of a blood donation, participants with 
HIV-positive test outcomes in 34 countries in Europe, logistic regression analysis, EMIS 2010.
Characteristics OR 95% CI
Age >2 5 years ref
≤25 years 2.3 1.6-3.5
Being out about sexual preference(s) Generally out ref
Out to a few people 1.6 1.2-2.2
Relationship with female partner(s) Not in a relationship with a female partner ref
In a relationship with female partner(s) 2.3 1.3-4.0
Anal intercourse with a male partner Ever ref
Never 1.1 0.13-8.1
Symptoms when STI screening (<12 months) STI test due to symptoms ref
No STI test 1.3 0.9-1.9
STI test without symptoms 0.6 0.8-1.6
Population size of place of residence ≥1,000,000  ref
500,000-999,999 1.1 0.8-1.6
100,000-499,999 1.7 1.2-2.3
10,000-99,999 1.6 1.2-2.3
<10,000 1.8 1.2-2.6
Region of residence (EMIS region) West ref
Southeast (EU) 0.9 0.1-6.8
Northwest 1.1 0.4-2.9
East 1.6 0.7-3.7
Central East 1.7 0.7-4.1
Southeast (non-EU) 2.3 0.5-9.7
Central West 2.3 1.6-3.3
Southwest 3.6 2.4-5.0
Northeast 8.6 2.9-26.1
HIV: human immunodeficiency virus; EMIS: European Men-who-have-sex-with-men Internet Survey; OR: odds ratio (bold: p≤0.05); 95% CI: 95% confidence 
interval; ref:  reference category; STI: sexually transmitted infection;  EU: European Union.
been affected; preliminary data covering the first two 
years following the change in deferral period showed 
no increase in HIV-positive blood donations22.
Although MSM are banned from donating blood 
in most European countries, the EMIS survey showed 
that 6.3% of participants reported having had their last 
HIV test within the context of a blood donation. In 
countries with a permanent deferral policy in place, 
5.4% of the reported last HIV tests took place in the 
context of a blood donation. This finding varies greatly 
among countries (range, 0.9-12.1%) and might reflect 
the availability, acceptance and ease of access to HIV 
testing services. 
The majority of participants (65%) reported testing in 
traditional medical settings such as general practitioners' 
and family doctors' offices, in private practices or as 
outpatients. In our study, these settings were more often 
reported by HIV-positive participants. By contrast, 
dedicated HIV testing services, mobile medical units, 
home testing, testing at bars, pubs, clubs and saunas, as 
well as blood establishments were more often reported as 
testing sites by HIV-negative participants. This finding 
might be attributable to more frequent screening and thus 
fewer diagnoses because, with the exception of blood 
establishments, these settings emphasise HIV screening.
EMIS data allowed us to determine characteristics 
of MSM who had either received their HIV diagnosis 
at a blood establishment or last tested HIV negative 
there. In many aspects, HIV-positive and -negative 
men did not differ. Compared to their peers who 
tested in regular settings, MSM who tested at blood 
establishments were younger and less open about their 
sexual preference. Notably, they were also more likely 
to be in a relationship with a woman. MSM frequenting 
blood establishments more commonly came from 
smaller towns and rural areas, suggesting -among other 
things- fewer regular testing sites and a lack of perceived 
anonymity/confidentiality at regular HIV testing sites 
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Table IIIb  - Factors associated with having been tested for HIV in the context of a blood donation, participants with 
HIV-negative test outcomes in 34 countries in Europe, logistic regression analysis, EMIS 2010.
Characteristics OR 95% CI
Age >25 years ref
≤25 years 2.3 2.1-2.4
Being out about sexual preference(s) Generally out ref
Out to a few people 1.8 1.7-1.9
Relationship with female partner(s) Not in a relationship with a female partner ref
In a relationship with female partner(s) 1.6 1.4-1.7
Anal intercourse with a male partner Ever ref
Never 1.9 1.7-2.1
Symptoms when STI screening (<12 months) STI test due to symptoms ref
No STI test 2.9 2.5-3.4
STI test without symptoms 2.3 2.0-2.7
Population size of place of residence ≥1,000,000 ref
500,000-999,999 1.2 1.1-1.4
100,000-499,999 1.4 1.3-1.5
10,000-99,999 1.8 1.6-1.9
<10,000 1.8 1.6-1.9
Region of residence (EMIS region) West ref
Northwest 1.5 1.2-1.9
East 3.9 3.2-4.7
Southeast (EU) 5.0 4.0-6.2
Central West 6.0 5.3-6.8
Central East 6.7 5.7-6.8
Southwest 6.9 6.0-7.8
Southeast (non-EU) 7.0 5.7-8.7
Northeast 9.5 7.4-12.0
OR: odds ratio (bold: p≤0.05); 95% CI: 95% confidence interval; ref: reference category; STI: sexually transmitted infection; EMIS: European Men-who-
have-sex-with-men Internet Survey; EU: European Union.
Figure 1 - Proportion of participants who had their last negative HIV test at a blood establishment by time elapsed since last 
test and EMIS Region, EMIS 2010.
 West (Belgium, France, Republic of Ireland, the Netherlands, United Kingdom); Northwest (Denmark, Finland, Norway, 
Sweden); East (Belarus, Russia, Ukraine); Southeast (EU) (Bulgaria, Cyprus, Romania); Central-West (Austria, Switzerland, 
Germany, Luxembourg); Southeast (non-EU) (Croatia, Serbia, Turkey); Southwest (Spain, Italy, Portugal, Greece); 
Central-East (Czech Republic, Hungary, Poland, Slovenia, Slovakia); Northeast (Estonia, Lithuania, Latvia). HIV: human 
immunodeficiency virus; EMIS: European Men-who-have-sex-with-men Internet Survey.
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as possible reasons for seeking HIV screening while 
donating blood. Difference in HIV status affected two 
factors: HIV-negative MSM at blood establishments 
were less likely to self-report ever having had anal 
intercourse and were also less likely to have screened 
for STI other than HIV within the preceding 12 months. 
These findings were not significant among those 
diagnosed HIV-positive in the context of a blood 
donation. This may be explained by the fact that STI 
testing, irrespectively of symptoms, is part of routine 
HIV care; it does not imply that men who tested positive 
within the context of a blood donation had already been 
screened for STI before being diagnosed with HIV. 
Routine annual STI testing, including HIV screening, is 
recommended to sexually active MSM in most countries 
by responsible authorities to identify infections early and 
prevent transmission23,24. Our results suggest that HIV-
negative MSM using blood establishments as testing 
sites are less well reached by this recommendation or 
do not have easy access to such combined testing sites 
or perceive barriers to access them and are, therefore, 
less likely to be screened for STI when asymptomatic. 
They also reported fewer STI tests due to symptoms 
within the preceding 12 months. 
An important factor characterising MSM testing 
at blood establishments was the country of residence, 
which we summarised by EMIS regions. Compared 
to the West region, the other regions ranged from 
having a small impact (testing 1.5 times more likely 
in the countries forming the Northwest region) to 
being the single largest predisposing factor (OR=9.5 
in the Northeast). For HIV-negative men, the region 
of residence was a statistically significant factor, while 
only three regions (Central-West, Southwest, Northeast) 
remained significant in the analysis of HIV-positive men. 
We expected to find that MSM frequenting blood 
establishments would report having no or limited access 
to HIV screening. Instead, this assumption was not 
confirmed, even among those who had been screened 
recently at blood establishments. This question was not 
significant in preliminary analysis and thus excluded 
from the regression model presented here. Blood 
establishments might be perceived as alternative HIV 
test settings. This should be discouraged because HIV 
testing in blood establishments is done for product 
safety and is not, therefore, accompanied by counselling. 
Although the residual risk of transfusion-transmitted 
HIV infections is very low, test-seeking donors with 
sexual risk exposures might pose a risk to blood safety 
because of window period donations or test failures. The 
fact that blood establishments are used as HIV testing 
sites underlines the need to improve donor selection. 
Donor selection could be refined by better donor 
questionnaires, by educating potential donors and by 
ensuring a confidential environment at the donation 
site9. Studies on unreported deferrable risks among 
donors demonstrated that the personal perception of 
risk is a key to non-compliance with donor selection 
criteria25,26. Well-designed donor history questionnaires 
and appropriate donor education material are, therefore, 
needed to prevent donations from individuals at risk 
of acquiring transfusion-transmissible infections9. In a 
recent study in Italy, 8.3% of HIV-positive repeat tested 
donors reporting a risk behaviour <4 months before 
donation stated that they had donated blood in order to 
be tested for HIV27. In another survey in Australia, the 
proportion of HIV-negative test-seekers among non-
compliant donors was lower (0.74%) but test-seeking 
donors had a significantly greater likelihood of non-
disclosure during the pre-donation assessment (adjusted 
OR, 2.39; 95% CI: 1.14-5.04) in the logistic regression28.
To assess whether blood establishments have 
become more or less popular testing sites among those 
screening negative, we compared the proportions of 
MSM reporting their last HIV screening from this setting 
among all test settings within three time frames (more 
than five years previously, between one and five years 
previously, within the preceding one year). We found that 
in the West, Northwest and East the proportions of men 
who tested at a blood establishment within the preceding 
year were lower than those of men living in the same 
regions who had tested longer ago. We do not, however, 
know why they chose other test settings. By contrast, in 
the Southeast (EU), Central-West, Southwest, Central-
East and Northeast the proportions of MSM who had 
tested at blood establishments among all sites within the 
preceding year were higher compared to the proportions 
who last tested longer ago. Regions in which the use of 
blood establishments was generally higher were also 
those in which larger proportions of MSM screened at 
blood establishments more recently. As discussed above, 
MSM who tested at blood establishments were not 
more likely to report a lack of testing facilities and they 
might have considered blood donation an appropriate 
setting. Yet in countries with more recent or less 
pronounced epidemics29-31, blood establishments play a 
more important role, possibly because these countries 
tend to have a less well or more recently established 
network of testing facilities. It is also possible that the 
recommendation for sexually active MSM to screen for 
HIV has reached this group and some might use blood 
donation to follow this advice in an easily accessible 
and stigma-free setting. The need to disclose sexual risk 
behaviours to get tested in other test settings may be a 
barrier for some MSM, particularly if there is no easy 
access to gay-friendly and anonymous testing services. 
This of course points to the need for public health actions 
to provide appropriate and acceptable test settings to 
meet these prevention needs and also safeguard the 
allogeneic blood supply. 
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Although home testing kits are available in only a few 
countries, 0.7% of EMIS participants reported having 
used such kits for their last HIV test. The EMIS survey 
did not go into details regarding whether home testing 
(e.g. analysing a specimen with a quick test at home) or 
home sampling (taking a specimen at home, sending it 
to a laboratory for analysis) was used. Home sampling 
may be particularly useful in rural areas in which the 
demand for specialised services might be too low to 
offer MSM friendly, convenient, readily accessible, 
sustainable and cost-effective services32. A study in the 
United Kingdom investigated targeted home sampling, 
i.e. when a lay-person collects their own specimen to 
send to a laboratory for analysis, while counselling is by 
phone and online. This study was promoted specifically 
for MSM and sub-Saharan migrants. Previously untested 
black African heterosexual women with more sexual 
partners and MSM were attracted by the convenience 
offered through home sampling and were reached 
successfully with this strategy33. Home sampling would 
have two main advantages: epidemiological data, such 
as age group and sex, could be sent anonymously to 
the laboratory to maintain surveillance and individuals 
seeking testing could be informed about risks and risk 
management and other needs for prevention (e.g. STI 
screening) while pointing them to the various appropriate 
settings. Given the convenience and confidentiality of 
the home setting, home sampling could be considered 
as an alternative for MSM who would otherwise screen 
for HIV by donating blood, in addition to optimising 
existing or creating new testing possibilities. 
Our study has a number of limitations. First, the 
EMIS sample was not random. The dataset was likely 
to be biased towards better educated, internet-literate 
MSM. This sample may have thus been less likely to seek 
HIV screening by donating blood. As a consequence, 
our study may underestimate the proportion of MSM 
who use blood donation centres to seek HIV testing. 
Second, the EMIS questionnaire did not differentiate 
MSM who donated blood in order to get tested from 
those who donated for other, e.g. altruistic, reasons, did 
not specify the number of past and planned subsequent 
donations, and did not specify whether donors had used a 
confidential unit exclusion option to withhold their blood 
from being used for transfusion. Because EMIS did not 
collect this information, the impact of these donations 
on blood safety cannot be estimated.
Conclusions
In conclusion, in most European countries sexually 
active MSM are permanently deferred from donating 
blood, and yet such individuals do donate blood and 
are screened for HIV in this context. MSM who are less 
open about their sexuality and who have poor access to 
anonymous or confidential MSM-friendly care in less 
densely populated areas more often use blood donation 
to screen for HIV. On the basis of these findings, we 
can formulate a number of recommendations. We need, 
first, a closer public health assessment to safeguard 
the blood supply and to offer appropriate prevention 
services and, second, local exploration of the reasons 
for increased proportions of MSM choosing to test at 
blood donation centres compared to other testing sites. 
Furthermore, we need to strengthen alternative testing 
capacities and consider novel testing approaches, such as 
home sampling for those not reached by existing testing 
avenues. Public health measures must, therefore, make 
sure that alternatives are made available to dissuade test 
seeking during blood donation by meeting screening 
needs outside this context. 
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